Connect with us
[bsa_pro_ad_space id=12]

COVID-19

Post Fauci NIH can’t help itself. Still misleading public about severity of COVID

Published

8 minute read

From the Brownstone Institute

By Ian Miller

NIH’s Latest Desperate Attempt to Incite Fear

The response to the Covid-19 pandemic revealed many concerning aspects of how government functions and how committed individuals and institutions are to maintaining their preferred narratives.

Truth, data, science, evidence…apparently none of those matter relative to the importance of ensuring the public complies with their desired behavior. Perhaps no single individual has been a better representation of the symbiotic relationship between government officials and media members, as well as their ceaseless commitment to ideological priorities, than Dr. Anthony Fauci.

Fauci’s NIAID and its parent organization, the National Institutes of Health, have been two of the most prolific spreaders of ideologically motivated misinformation ever during the pandemic. But Fauci is no longer part of NIH, having departed for the considerable financial rewards available from the private sector.

So as a result of his timely exit, we must finally be witnessing improvements regarding government studies and communication, right? Right?

Not exactly.

Government Covid Misinformation Continues Unabated

A triumphant, breathless press release from the National Institutes of Health was just released in the past week covering a new study that claimed a horrifying new conclusion. Contracting Covid-19 once is bad, but God forbid you experience two bouts of the virus…It’s terrifying.

That’s their claim resulting from utilizing massive volumes of “health data” on over 200,000 Americans who they believe had Covid at least once over a two-and-a-half-year period from 2020-2022.

“Those individuals were originally infected between March 1, 2020-Dec. 31, 2022, and experienced a second infection by March 2023. Most participants (203,735) had Covid-19 twice, but a small number (478) had it three times or more,” the study says.

The conclusion, is at first glance, concerning.

“Using health data from almost 213,000 Americans who experienced reinfections, researchers have found that severe infections from the virus that causes COVID-19 tend to foreshadow similar severity of infection the next time a person contracts the disease. Additionally, scientists discovered that long COVID was more likely to occur after a first infection compared to a reinfection,” the NIH summary claims.

That sounds pretty bad. If you get infected a second time, you’re likely to experience a severe case of Covid. Right?

Except that is a completely inaccurate conclusion based on the limited data presented.

“About 27% of those with severe cases, defined as receiving hospital care for a coronavirus infection, also received hospital care for a reinfection. Adults with severe cases were more likely to have underlying health conditions and be ages 60 or older. In contrast, about 87% of those who had mild Covid cases that did not require hospital care the first time also had mild cases of reinfections,” the researchers write.

And there’s the real story, hidden in plain sight.

We know from years of experience that Covid significantly impacts those who are in poor health, have underlying conditions, or are older AND in poor health. We also know that a very small percentage of Covid cases require treatment in a hospital setting.

All this study shows is that those who are in poor health, have underlying conditions, or are older, are more likely to need additional care if they get Covid a second time. Even then, 73% of those who had a second infection and were hospitalized the first time did not need hospitalization for the second infection. Sure enough, the vast, vast majority of those who had mild Covid cases the first time had mild Covid cases the second time.

The protection from natural immunity is highly important and generally durable, though less so when an individual with poor underlying health has contracted the virus. This is nothing new. But that didn’t stop the new head of the NIH from spouting some impressive fear-mongering and bad science.

NIH Can’t Stop Getting Things Wrong

Dr. Monica Bertagnolli posted a link to the study on X, and a short summary. She repeated the same line about the severity of Covid reinfections, which were intended to undermine the importance of natural immunity.

And more importantly, she claimed that the results underscore “the importance of preventing infection.”

After analyzing data from 200K Americans who had #COVID19 twice, researchers found that a severe #COVID case tended to foreshadow a similarly severe infection the second time, underscoring the importance of preventing infection[.]

Except that’s an impossibility. SARS-CoV-2 is an endemic virus. It will never be eliminated. It will never be stopped. Infection cannot be avoided. Vaccinations don’t prevent it, masks surely are ineffective, and any public interaction may result in an infection.

There simply is no way to prevent infection, which is why some countries have now reported that roughly 70% of their population, even with masking and vaccination, have tested positive. Telling those at risk to try to avoid infection is irresponsible and inaccurate. So why is this coming from the NIH?

Sure enough, these researchers also accidentally made the case for natural immunity. When studying the nonexistent phenomenon of “long Covid,” they found that those who had typical, longer-lasting effects from viral infections had bigger reactions after their first infection.

“Scientists also discovered that regardless of the variant, long Covid cases were more likely to occur after a first infection compared to a reinfection,” the study says.

Why is that? Because of natural immunity.

Under Anthony Fauci, they spent years downplaying it. They continue to undermine it in 2024. But the reality and the science continue to prove that natural immunity is protective and durable, and this is especially true for those in good health and younger age groups. Imagine if government agencies had been willing to admit this in 2020 instead of pointlessly locking down all of society in order to somehow prevent a virus that cannot be prevented.

That would have been the correct evaluation and communication.

But since when have government agencies handled a single aspect of Covid correctly?

Republished from the author’s Substack

Author

Ian Miller is the author of “Unmasked: The Global Failure of COVID Mask Mandates.” His work has been featured on national television broadcasts, national and international news publications and referenced in multiple best selling books covering the pandemic. He writes a Substack newsletter, also titled “Unmasked.”

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

COVID-19

Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

Published on

From LifeSiteNews

By Nicolas Hulscher, MPH

A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna

A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.

The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:

Study Overview

  • Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
  • Intervention: Two doses of either:
    • BNT162b2 (Pfizer-BioNTech)
    • mRNA-1273 (Moderna)
  • Follow-up Duration: 12 months after second dose.
  • Comparison: Head-to-head between Pfizer vs. Moderna recipients.
  • Main Outcomes:
    • All-cause mortality
    • Cardiovascular mortality
    • COVID-19 mortality
    • Non-COVID-19 mortality

All-cause mortality

Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.

  • Pfizer Risk: 847.2 deaths per 100,000 people
  • Moderna Risk: 617.9 deaths per 100,000 people
  • Risk Difference:
    ➔ +229.2 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.37 (i.e., 37% higher mortality risk with Pfizer)
  • Odds Ratio (Adjusted):
    ➔ 1.384 (95% CI: 1.331–1.439)

Cardiovascular mortality

Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.

  • Pfizer Risk: 248.7 deaths per 100,000 people
  • Moderna Risk: 162.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +86.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.53 (i.e., 53% higher cardiovascular mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.540 (95% CI: 1.431–1.657)

COVID-19 mortality

Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.

  • Pfizer Risk: 55.5 deaths per 100,000 people
  • Moderna Risk: 29.5 deaths per 100,000 people
  • Risk Difference:
    ➔ +26.0 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.88 (i.e., 88% higher COVID-19 mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.882 (95% CI: 1.596–2.220)

Non-COVID-19 mortality

Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.

  • Pfizer Risk: 791.6 deaths per 100,000 people
  • Moderna Risk: 588.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +203.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.35 (i.e., 35% higher non-COVID mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.356 (95% CI: 1.303–1.412)

Biological explanations

The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:

The paper hypothesizes differences between Pfizer and Moderna may be due to:

  • Different lipid nanoparticle compositions
  • Differences in manufacturing, biodistribution, or storage conditions

Final conclusion

Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.

Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.

As the authors conclude:

These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.

Reprinted with permission from Focal Points.

Continue Reading

COVID-19

Canada’s health department warns COVID vaccine injury payouts to exceed $75 million budget

Published on

Fr0m LifeSiteNews

By Clare Marie Merkowsky

A Department of Health memo warns that Canada’s Vaccine Injury Support Program will exceed its $75 million budget due to high demand, with $16 million already paid out.

COVID vaccine injury payments are expected to go over budget, according to a Canadian Department of Health memo.

According to information published April 28 by Blacklock’s Reporter, the Department of Health will exceed their projected payouts for COVID vaccine injuries, despite already spending $16 million on compensating those harmed by the once-mandated experimental shots.

“A total $75 million in funding has been earmarked for the first five years of the program and $9 million on an ongoing basis,” the December memo read. “However the overall cost of the program is dependent on the volume of claims and compensation awarded over time, and that the demand remains at very high levels.”

“The purpose of this funding is to ensure people in Canada who experience a serious and permanent injury as a result of receiving a Health Canada authorized vaccine administered in Canada on or after December 8, 2020 have access to a fair and timely financial support mechanism,” it continued.

Canada’s Vaccine Injury Support Program (VISP) was launched in December 2020 after the Canadian government gave vaccine makers a shield from liability regarding COVID-19 jab-related injuries.

While Parliament originally budgeted $75 million, thousands of Canadians have filed claims after received the so-called “safe and effective” COVID shots. Of the 3,060 claims received to date, only 219 had been approved so far, with payouts totaling over $16 million.

Since the start of the COVID crisis, official data shows that the virus has been listed as the cause of death for less than 20 kids in Canada under age 15. This is out of six million children in the age group.

The COVID jabs approved in Canada have also been associated with severe side effects such as blood clots, rashes, miscarriages, and even heart attacks in young, healthy men.

Additionally, a recent study done by researchers with Canada-based Correlation Research in the Public Interest showed that 17 countries have found a “definite causal link” between peaks in all-cause mortality and the fast rollouts of the COVID shots as well as boosters.

Interestingly, while the Department of Health has spent $16 million on injury payouts, the Liberal government spent $54 million COVID propaganda promoting the vaccine to young Canadians.

The Public Health Agency of Canada especially targeted young Canadians ages 18-24 because they “may play down the seriousness of the situation.”

The campaign took place despite the fact that the Liberal government knew about COVID vaccine injuries, according to a secret memo.

Continue Reading

Trending

X